University-Associated SARS-CoV-2 Omicron BA.2 Infections, Maricopa County, Arizona, USA, 2022Article Published on 2022-07-012023-07-09 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), [키워드] Arizona BA.2 subvariant coronavirus coronavirus disease COVID-19 disease outbreaks Epidemiology investigation omicron respiratory infections SARS SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 United States viruses zoonoses [DOI] 10.3201/eid2807.220470 PMC 바로가기
Immune-based therapeutic approaches in COVID-19COVID-19의 면역 기반 치료 접근법Review Published on 2022-07-012022-09-12 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, [키워드] acute respiratory syndrome antibodies approach ARDS caused Complication coronavirus Coronavirus disease 2019 Coronavirus-2 Corticosteroids COVID-19 COVID-19 pathogenesis COVID-19 research Cytokine storm syndrome eliminating Epidemic immune immune system Immunotherapy interferon Intravenous immunoglobulin IVIG measure monoclonal antibody not applicable pandemic pathogen physical Pneumonia SARS SARS-CoV-2 social distancing the Coronaviridae the disease Therapeutic approach therapy Treatment vaccination viral disease WHO World Health Organization [DOI] 10.1016/j.biopha.2022.113107 PMC 바로가기 [Article Type] Review
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies분무형 HepArin이 침습적 인공호흡이 필요한 COVID-19 환자의 사망률과 발관까지의 시간을 줄일 수 있습니까?Article Published on 2022-07-012022-09-11 Journal: British Journal of Clinical Pharmacology [Category] COVID19(2023년), SARS, 임상, [키워드] Activation alveolar fibrin Analysis Anti-inflammatory ARDS blinded Can clinical study clinical trial Coagulation controlled clinical trials country COVID-19 COVID-19 pneumonia dataset days alive defined Effect endpoints Evidence extubation FIBRIN FIVE heparin hypoxaemic respiratory failure Infection Inhaled International invasive ventilation investigator-initiated Laboratory limit lung Lung injury mammalian cells meta-trial Microvascular thrombosis nebulised heparin open label pandemic patient data patients with COVID-19 Placebo placebo-controlled Pneumonia Prevent Primary outcome progression randomised randomised controlled randomised study RCT receive Respiratory failure resulting SARS SARS-CoV-2 SARS-CoV-2 virus standard care Statistical analysis plan the SARS-CoV-2 virus therapy thrombosis unfractionated heparin ventilator-free day Ventilator-free days with COVID-19 [DOI] 10.1111/bcp.15253 PMC 바로가기 [Article Type] Article
Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022면역억제 환자의 지속적인 SARS-CoV-2 알파 변이체 감염, 프랑스, 2022년 2월Article Published on 2022-07-012022-09-11 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alpha variant circulation coronavirus coronavirus disease COVID-19 France Immunosuppressed Infection Mutation mutations Patient persistent respiratory infections SARS SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 variant variants variants of concern virus viruses zoonoses [DOI] 10.3201/eid2807.220467 PMC 바로가기 [Article Type] Article
Identification of potential pan-coronavirus therapies using a computational drug repurposing platform계산 약물 재검사 플랫폼을 사용한 잠재적 팬-코로나 바이러스 요법의 식별Article Published on 2022-07-012022-08-31 Journal: Methods (San Diego, Calif.) [Category] COVID19(2023년), SARS, 신약개발, 치료제, [키워드] acute respiratory syndrome approach approved drug approved drugs artificial Artificial neural network causative agent clinical trials Computational drug coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 datasets disease disease outbreaks drug Drug mechanism Drug repurposing drugs effective facilitate Human identification Infectious disease infectious disease outbreak information mechanism mechanism of action methodology novel Outbreaks pandemic Pathways platform PPI PPI network predicted protein-protein interaction rapid response Replication respiratory SARS SARS-CoV seriously ill patients Severe acute respiratory syndrome therapeutic therapy Treatment Validity virus replication Zoonotic coronavirus [DOI] 10.1016/j.ymeth.2021.11.002 PMC 바로가기 [Article Type] Article
Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In VitroSARS-CoV-2 감염의 광역학적 비활성화 및 시험관 내 항바이러스 치료 효과Article Published on 2022-06-142022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 antibody Antiviral Antiviral agents approach Cell cell cultures cell viability Concentration coronavirus Coronavirus-2 COVID-19 Critical Culture current death detectable Effect heat-inactivated in vivo inactivation Infection infectiousness Infectivity log measure Microscopy mitochondrial Mutation near-infrared light pandemic Pathogens PDI photodynamic inactivation photodynamic therapy photosensitizer Potential treatment qPCR reduce reduced reduction required SARS SARS-CoV-2 SARS-CoV-2 isolate severe acute respiratory syndrome Coronavirus severe disease significantly THPTS Toxicity Treatment uninfected Vaccines variety Vero Cell viability viral cytopathic effect viral infection viral infections Viral load Viral RNA virion virus virus load virus suspension viruses were assessed [DOI] 10.3390/v14061301 PMC 바로가기 [Article Type] Article
Contact tracing-induced Allee effect in disease dynamicsArticle Published on 2022-06-072023-07-08 Journal: Journal of theoretical biology [Category] COVID19(2023년), [키워드] Allee effect Alternative states Non-pharmaceutical interventions Outbreak threshold SARS Super-spreader Super-spreading TEst-TRace-ISolate. TETRIS [DOI] 10.1016/j.jtbi.2022.111109 PMC 바로가기
Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 20222022년 2월 홍콩 도착 여행자의 재조합 BA.1/BA.2 SARS-CoV-2 바이러스Article Published on 2022-06-012022-09-11 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus 2 addition breakpoint coronavirus coronavirus disease COVID-19 Delta epidemiologically Hong Kong omicron recombinant respiratory infections SARS SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genomes severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 spike gene Surveillance variants viruses zoonoses [DOI] 10.3201/eid2806.220523 PMC 바로가기 [Article Type] Article
COVID-19 pandemic response in one of the world’s most complex and vulnerable settingsEditorial Published on 2022-06-012023-07-09 Journal: BMJ Global Health [Category] COVID19(2023년), [키워드] COVID-19 public health respiratory infections SARS [DOI] 10.1136/bmjgh-2022-009911 PMC 바로가기 [Article Type] Editorial
Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster VaccinationBNT162b2 추가 백신 접종 후 SARS-CoV-2 Omicron BA.1 및 BA.2의 혈청 중화Article Published on 2022-06-012022-09-11 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus 2 BA.1 BA.2 BNT162b2 Booster vaccine coronavirus coronavirus disease COVID-19 Denmark isolate lineages median neutralization titer neutralization titers neutralized omicron replacing respiratory infections SARS SARS-CoV-2 serum Serum Neutralization serum sample serum samples severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Vaccine variant viruses zoonoses [DOI] 10.3201/eid2806.220503 PMC 바로가기 [Article Type] Article